Hepatitis C Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have never been treated for Hepatitis C before, and you received one of two specific Hepatitis C treatments (called GLE/PIB or SOF/VEL) between April 1st, 2018, and July 1st, 2023, while also taking at least one other medication or recreational drug at the same time.
- You were treated at a hospital that uses electronic medical records, which allowed full access to your clinic visits and all medications prescribed to you — both at the hospital and through your local GP or health centre — during the study period in Spain.
Who may not be able to join:
- You have previously been treated for Hepatitis C before the treatment mentioned above (i.e., you are not a first-time Hepatitis C patient).
- You were not taking any other medications or recreational drugs alongside your Hepatitis C treatment.
- You received your healthcare through a private healthcare provider rather than the public health system.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +34 955 01 85 36
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Main Study End Point
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.